Skip to main content
. 2018 May 16;53(2):620–632. doi: 10.3892/ijo.2018.4408

Table III.

mRNA expression of TRIM27 in colorectal carcinoma and adjacent normal tissues.

Clinical feature n (%) TRIM27 expression
P-value
High, n (%) Low, n (%)
Sex 40 40
 Male 52 (65.0) 25 (31.3) 27 (33.8) 0.639
 Female 28 (35.0) 15 (18.7) 13 (16.2)
Age (years)
 >60 36 (45.0) 17 (21.3) 19 (23.8) 0.653
 ≤60 44 (55.0) 23 (28.7) 21 (26.2)
Depth of invasion
 T1/T2 21 (26.3) 5 (6.3) 16 (20.0) 0.005b
 T3/T4 59 (73.7) 35 (43.7) 24 (30.0)
Lymph node metastasis
 Absent 39 (48.8) 14 (17.5) 25 (31.3) 0.014a
 Present 41 (51.2) 26 (32.5) 15 (18.7)
Tumor stage
 I/II 37 (46.3) 12 (15.0) 25 (31.2) 0.004b
 III/IV 43 (53.7) 28 (35.0) 15 (18.8)
Liver metastasis
 Yes 10 (12.5) 8 (10.0) 2 (2.5) 0.043a
 No 70 (87.5) 32 (40.0) 38 (47.5)
Location
 Rectum 35 (43.8) 19 (23.8) 16 (20.0) 0.499
 Colon 45 (56.2) 21 (26.2) 24 (30.0)
CEA (ng/ml)
 <4.7 31 (38.8) 13 (16.2) 18 (22.5) 0.250
 >4.7 49 (61.2) 27 (33.8) 22 (27.5)
a

P<0.05;

b

P<0.01. TRIM27, tripartite motif-containing 27.